132 related articles for article (PubMed ID: 17070147)
1. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
Russell M; Fleg JL; Galloway WJ; Henderson JA; Howard J; Lee ET; Poolaw B; Ratner RE; Roman MJ; Silverman A; Stylianou M; Weir MR; Wilson C; Yeh F; Zhu J; Howard BV
Am Heart J; 2006 Nov; 152(5):867-75. PubMed ID: 17070147
[TBL] [Abstract][Full Text] [Related]
2. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
Howard BV; Roman MJ; Devereux RB; Fleg JL; Galloway JM; Henderson JA; Howard WJ; Lee ET; Mete M; Poolaw B; Ratner RE; Russell M; Silverman A; Stylianou M; Umans JG; Wang W; Weir MR; Weissman NJ; Wilson C; Yeh F; Zhu J
JAMA; 2008 Apr; 299(14):1678-89. PubMed ID: 18398080
[TBL] [Abstract][Full Text] [Related]
3. Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.
Roman MJ; Howard BV; Howard WJ; Mete M; Fleg JL; Lee ET; Devereux RB
Hypertension; 2011 Sep; 58(3):367-71. PubMed ID: 21788602
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .
Wilson C; Huang CC; Shara N; Howard BV; Fleg JL; Henderson JA; Howard WJ; Huentelman H; Lee ET; Mete M; Russell M; Galloway JM; Silverman A; Stylianou M; Umans J; Weir MR; Yeh F; Ratner RE
J Clin Lipidol; 2010; 4(3):165-72. PubMed ID: 20563294
[TBL] [Abstract][Full Text] [Related]
5. Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience.
Mete M; Wilson C; Lee ET; Silverman A; Russell M; Stylianou M; Umans JG; Wang W; Howard WJ; Ratner RE; Howard BV; Fleg JL
J Diabetes Complications; 2011; 25(6):362-7. PubMed ID: 21775166
[TBL] [Abstract][Full Text] [Related]
6. Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
Fleg JL; Mete M; Howard BV; Umans JG; Roman MJ; Ratner RE; Silverman A; Galloway JM; Henderson JA; Weir MR; Wilson C; Stylianou M; Howard WJ
J Am Coll Cardiol; 2008 Dec; 52(25):2198-205. PubMed ID: 19095139
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.
Weir MR; Yeh F; Silverman A; Devereux RB; Galloway JM; Henderson JA; Howard WJ; Russell M; Wilson C; Ratner R; Sorkin J; Umans JG; Fleg JL; Stylianou M; Lee E; Howard BV
J Clin Hypertens (Greenwich); 2009 Oct; 11(10):540-8. PubMed ID: 19817934
[TBL] [Abstract][Full Text] [Related]
8. Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study.
Russell M; Silverman A; Fleg JL; Lee ET; Mete M; Weir M; Wilson C; Yeh F; Howard BV; Howard WM
J Clin Lipidol; 2010; 4(5):435-43. PubMed ID: 21076630
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
[TBL] [Abstract][Full Text] [Related]
10. Intensive statin therapy for Indians: Part-I. Benefits.
Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
[TBL] [Abstract][Full Text] [Related]
11. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.
Howard BV; Robbins DC; Sievers ML; Lee ET; Rhoades D; Devereux RB; Cowan LD; Gray RS; Welty TK; Go OT; Howard WJ
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):830-5. PubMed ID: 10712410
[TBL] [Abstract][Full Text] [Related]
12. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
13. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
Goldberg RB
Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
[TBL] [Abstract][Full Text] [Related]
14. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
15. Can group medical clinics improve lipid management in diabetes?
Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
[TBL] [Abstract][Full Text] [Related]
16. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
18. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
[TBL] [Abstract][Full Text] [Related]
19. Nutritional management of cardiovascular risk factors. A randomized clinical trial.
McCarron DA; Oparil S; Chait A; Haynes RB; Kris-Etherton P; Stern JS; Resnick LM; Clark S; Morris CD; Hatton DC; Metz JA; McMahon M; Holcomb S; Snyder GW; Pi-Sunyer FX
Arch Intern Med; 1997 Jan; 157(2):169-77. PubMed ID: 9009974
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
